| P50 | author | Rebecca King | Q47965489 |
| | Jonathan Kevin Sia | Q59680408 |
| | Bali Pulendran | Q88744806 |
| P2093 | author name string | Ranjna Madan-Lala | |
| | Shabaana A Khader | |
| | Jyothi Rengarajan | |
| | Toidi Adekambi | |
| | Leticia Monin | |
| P2860 | cites work | Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages | Q28301043 |
| | Characterization of a novel cell wall-anchored protein with carboxylesterase activity required for virulence in Mycobacterium tuberculosis | Q28486765 |
| | Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages | Q28486898 |
| | Mycobacterium tuberculosis Rv2224c modulates innate immune responses | Q28487461 |
| | Dendritic cells and other innate determinants of T helper cell polarisation. | Q38131249 |
| | Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung | Q39319543 |
| | Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages | Q40204492 |
| | Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. | Q40313140 |
| | Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms | Q40558720 |
| | Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. | Q41691011 |
| | Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro | Q44275809 |
| | Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. | Q44532320 |
| | Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs | Q44576601 |
| | A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells | Q47810460 |
| | Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells | Q47991722 |
| | Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. | Q50671032 |
| | A role for dendritic cells in the dissemination of mycobacterial infection. | Q50730599 |
| | Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. | Q51024915 |
| | Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. | Q51824924 |
| | In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. | Q51989388 |
| | Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. | Q52956682 |
| | A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response | Q59057817 |
| | Dendritic Cells Are Host Cells for Mycobacteria In Vivo That Trigger Innate and Acquired Immunity | Q61053105 |
| | Activation of human dendritic cells following infection with Mycobacterium tuberculosis | Q73500935 |
| | Mycobacteria target DC-SIGN to suppress dendritic cell function | Q28616857 |
| | Immunobiology of dendritic cells | Q29547465 |
| | Dendritic cells: specialized and regulated antigen processing machines | Q29617085 |
| | Disseminated tuberculosis in interferon gamma gene-disrupted mice | Q29619812 |
| | Programming the magnitude and persistence of antibody responses with innate immunity | Q30400144 |
| | The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells | Q33318121 |
| | Inflammatory cytokines as a third signal for T cell activation | Q33936084 |
| | Fate of Mycobacterium tuberculosis within murine dendritic cells | Q34005925 |
| | Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis | Q34044493 |
| | Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. | Q34127776 |
| | Immune evasion by Mycobacterium tuberculosis: living with the enemy | Q34219869 |
| | Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. | Q34448382 |
| | The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. | Q35165161 |
| | Mycobacterial survival strategies in the phagosome: defence against host stresses | Q35205535 |
| | Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? | Q35566913 |
| | Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 |
| | Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation | Q35598079 |
| | Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses | Q36218547 |
| | DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells | Q36370434 |
| | TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. | Q36403076 |
| | Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response | Q36416118 |
| | Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs | Q36446956 |
| | Who puts the tubercle in tuberculosis? | Q36679224 |
| | Host innate immune response to Mycobacterium tuberculosis | Q36761305 |
| | ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes | Q36825301 |
| | Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection | Q36916383 |
| | Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment | Q37051339 |
| | Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. | Q37360655 |
| | Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis | Q37375293 |
| | Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. | Q37401744 |
| | Spotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge? | Q37668208 |
| | Cellular response to mycobacteria: balancing protection and pathology | Q37826931 |
| | The immunological life cycle of tuberculosis | Q38025869 |
| | Dendritic cell subsets in mycobacterial infection: control of bacterial growth and T cell responses | Q38061211 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 4263-4272 | |
| P577 | publication date | 2014-03-21 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1. | |
| P478 | volume | 192 | |